These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 8616061)
1. Elevated serum interleukin-6 (IL-6) is derived from neoplastic lymphoid cells in patients with B-cell non-Hodgkin's lymphoma: correlation with extent of IL-6 expression and serum concentration. Kato H; Kinoshita T; Suzuki S; Nagasaka T; Murate T; Saito H; Hotta T Br J Haematol; 1996 Mar; 92(4):1014-21. PubMed ID: 8616061 [TBL] [Abstract][Full Text] [Related]
2. Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors. Voorzanger N; Touitou R; Garcia E; Delecluse HJ; Rousset F; Joab I; Favrot MC; Blay JY Cancer Res; 1996 Dec; 56(23):5499-505. PubMed ID: 8968107 [TBL] [Abstract][Full Text] [Related]
3. Increased frequency of circulating Th22 cells in patients with B-cell non-Hodgkin's lymphoma. Lu T; Liu Y; Yu S; Yin C; Li P; Ye J; Ma D; Ji C Oncotarget; 2016 Aug; 7(35):56574-56583. PubMed ID: 27489357 [TBL] [Abstract][Full Text] [Related]
4. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma. Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065 [TBL] [Abstract][Full Text] [Related]
5. Th1/Th2 cytokine expression and its relationship with tumor growth in B cell non-Hodgkin's lymphoma (NHL). Jones EA; Pringle JH; Angel CA; Rees RC Leuk Lymphoma; 2002 Jun; 43(6):1313-21. PubMed ID: 12153001 [TBL] [Abstract][Full Text] [Related]
6. Production and effects of interleukin-6 and other cytokines in patients with non-Hodgkin's lymphoma. Kato H; Kinoshita T; Suzuki S; Nagasaka T; Hatano S; Murate T; Saito H; Hotta T Leuk Lymphoma; 1998 Mar; 29(1-2):71-9. PubMed ID: 9638977 [TBL] [Abstract][Full Text] [Related]
7. [Diagnostic and prognostic value of interleukin-6 in malignant non-Hodgkin's lymphomas]. Serebriakov NB; Novik AA; Shamanskiĭ SV; Krivolapov IuA; Voloshin SV; D'iakova VV; Snetkova IG; Katkova IV; Zhiburt EB Vestn Ross Akad Med Nauk; 1998; (10):32-6. PubMed ID: 9846110 [TBL] [Abstract][Full Text] [Related]
9. [Correlation of cyclooxygenase-2 expression to P-glycoprotein expression in B-cell non-Hodgkin's lymphoma]. Li B; Zhong MZ; Tang TF; Liu W; Huang J Ai Zheng; 2007 Aug; 26(8):851-5. PubMed ID: 17697546 [TBL] [Abstract][Full Text] [Related]
10. Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma. Feldmann G; Nischalke HD; Nattermann J; Banas B; Berg T; Teschendorf C; Schmiegel W; Dührsen U; Halangk J; Iwan A; Sauerbruch T; Caselmann WH; Spengler U Clin Cancer Res; 2006 Aug; 12(15):4491-8. PubMed ID: 16899594 [TBL] [Abstract][Full Text] [Related]
11. Increased IL-6 detection in adult and pediatric lymphoid tissue harboring parvovirus B19. Polcz ME; Adamson LA; Lu X; Chang MN; Fowler LJ; Hobbs JA J Clin Virol; 2013 Jul; 57(3):233-8. PubMed ID: 23522566 [TBL] [Abstract][Full Text] [Related]
12. CD38 and interleukin 6 gene polymorphism in egyptians with diffuse large B-cell lymphoma (DLBCL). Talaat RM; Abdel-Aziz AM; El-Maadawy EA; Abdel-Bary N Immunol Invest; 2015; 44(3):265-78. PubMed ID: 25564959 [TBL] [Abstract][Full Text] [Related]
13. Real-time polymerase chain reaction determination of cytokine mRNA expression profiles in Hodgkin's lymphoma. Malec M; Söderqvist M; Sirsjö A; MacNamara B; Lewin N; Sjöberg J; Björkholm M; Porwit-MacDonald A Haematologica; 2004 Jun; 89(6):679-85. PubMed ID: 15194535 [TBL] [Abstract][Full Text] [Related]
14. The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours. Luciani MG; Stoppacciaro A; Peri G; Mantovani A; Ruco LP Mol Pathol; 1998 Oct; 51(5):273-6. PubMed ID: 10193522 [TBL] [Abstract][Full Text] [Related]
15. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms. Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913 [TBL] [Abstract][Full Text] [Related]
16. Serum levels of interleukin-6 and interleukin-10 in Turkish patients with aggressive non-Hodgkin's lymphoma. Guney N; Soydinc HO; Basaran M; Bavbek S; Derin D; Camlica H; Yasasever V; Topuz E Asian Pac J Cancer Prev; 2009; 10(4):669-74. PubMed ID: 19827892 [TBL] [Abstract][Full Text] [Related]
17. Aurora2/BTAK/STK15 is involved in cell cycle checkpoint and cell survival of aggressive non-Hodgkin's lymphoma. Hamada M; Yakushijin Y; Ohtsuka M; Kakimoto M; Yasukawa M; Fujita S Br J Haematol; 2003 May; 121(3):439-47. PubMed ID: 12716366 [TBL] [Abstract][Full Text] [Related]
18. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma. Gonzalez CL; Medeiros LJ; Jaffe ES Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease. Hsu SM; Xie SS; Hsu PL; Waldron JA Am J Pathol; 1992 Jul; 141(1):129-38. PubMed ID: 1632458 [TBL] [Abstract][Full Text] [Related]
20. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma. van den Berg A; Visser L; Poppema S Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]